Evidence map›Paper›PMID 40093265›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Hospital wastewater surveillance for SARS-CoV-2 identifies intra-hospital dynamics of viral transmission and evolution.

Medini K Annavajhala, Anne L Kelley, Lingsheng Wen, Maya Tagliavia, Sofia Moscovitz, Heekuk Park, Simian Huang, Jason Zucker, Anne-Catrin Uhlemann

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Medini K AnnavajhalaDivision of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032.ORCID 0000-0002-9229-8849
Anne L KelleyDivision of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032.
Lingsheng WenDivision of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032.ORCID 0009-0003-0433-0218
Maya TagliaviaDivision of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032.
Sofia MoscovitzDivision of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032.
Heekuk ParkDivision of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032.ORCID 0000-0001-5815-9717
Simian HuangDivision of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032.ORCID 0000-0001-5536-1231
Jason ZuckerDivision of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032.ORCID 0000-0001-6987-6412
Anne-Catrin UhlemannDivision of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032.ORCID 0000-0002-9798-4768

Funding

Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.U01DA053949 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CHANDRAN, KARTIK, UHLEMANN, ANNE-CATRIN · 2021 to 2022
$4.8M
Operationalizing wastewater-based surveillance of multidrug-resistant bacteriaR00AI163348 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI Medini K Annavajhala · 2024 to 2026
$590k
Operationalizing wastewater-based surveillance of multidrug-resistant bacteriaK99AI163348 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ANNAVAJHALA, MEDINI K · 2022 to 2023
$251k
NCATS NIH HHS UL1 TR001873NIAID NIH HHS K99 AI163348NIAID NIH HHS R00 AI163348NIDA NIH HHS U01 DA053949
6 · The paper itself

Abstract

Wastewater testing has emerged as an effective, widely used tool for population-level SARS-CoV-2 surveillance. Such efforts have primarily been implemented at the wastewater treatment plants (WWTPs), providing data for large resident populations but hindering the ability to implement targeted interventions or follow-ups. Conversely, building-level wastewater data exhibits increased variability due to rapid daily population dynamics but allows for targeted follow-up interventions or mitigation efforts. Here, we implemented a three-site wastewater sampling strategy on our university-affiliated medical campus from May 2021 to March 2024, comprised of two distinct hospital quadrants and a primarily research laboratory and classroom building. We first addressed several limitations in implementing hospital-level wastewater surveillance by optimizing sampling frequency and laboratory techniques. We subsequently improved our ability to model SARS-CoV-2 case counts using wastewater data by performing sensitivity analyses on viral shedding assumptions and testing the utility of internal normalization factors for population size. Our unique infrastructure allowed us to detect intra-hospital dynamics of SARS-CoV-2 prevalence and diversity and confirmed that direct sequencing of wastewater was able to capture corresponding clinical viral diversity. In contrast, research building wastewater sampling showed that for most non-residential settings, despite low overall viral loads, a threshold approach can still be used to identify peaks in cases or transmission amongst the general population. Our study expands on current wastewater surveillance practices by examining the utility of and best practices for upstream and particularly hospital settings, enabling the use of non-municipal, medium-scale wastewater testing to inform efforts for reducing the burden of COVID-19.

Indexed as

COVID-19hospital wastewaterSARS-CoV-2wastewater-based epidemiologywastewater surveillance

Identifiers

PMID40093265
PMCPMC11908291

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.